Skip to main navigation Skip to search Skip to main content

Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases

  • Sergio D. Bergese
  • , Babak Khabiri
  • , William D. Roberts
  • , Michael B. Howie
  • , Thomas D. McSweeney
  • , Mark A. Gerhardt
  • Ohio State University

Research output: Contribution to journalArticlepeer-review

91 Scopus citations

Abstract

Currently used methods of sedation for fiberoptic intubation such as benzodiazepines, propofol, or opioids have their limitations. Dexmedetomidine (DEX) is a selective α-2 adrenergic agonist that has been used clinically for its sympatholytic, analgesic, and sedative properties. We report on 4 patients with particularly difficult airways who underwent successful awake fiberoptic intubation with DEX. Dexmedetomidine was used to provide a moderate level of conscious sedation without causing respiratory distress or hemodynamic instability during fiberoptic intubation.

Original languageEnglish
Pages (from-to)141-144
Number of pages4
JournalJournal of Clinical Anesthesia
Volume19
Issue number2
DOIs
StatePublished - Mar 2007

Keywords

  • Awake fiberoptic
  • Conscious sedation
  • Dexmedetomidine
  • Difficult airway
  • Intubation
  • Sedation

Fingerprint

Dive into the research topics of 'Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases'. Together they form a unique fingerprint.

Cite this